DeutschNewstral
Article
Ppacbiztimes.com on 2017-11-20 22:55
Amgen invests in precision oncology startup Syapse
Related news
- PAmgen closes deal for $2.8B stake in oncology firm BeiGenepacbiztimes.com
- PAmgen seeks license for biosimilar version of oncology drug Rituxanpacbiztimes.com
- PAmgen partners with software firm to address oncology patientspacbiztimes.com
Neurodegeneration startup launches with $50M, Amgen assetsbizjournals.com- GSK's head of oncology jumps to Boston precision medicine startupbizjournals.com
- UPMC Enterprises invests in oncology diagnostics firmbizjournals.com
- FAmgen invests £50m in Oxford Nanoporeft.com
- PAmgen Ventures invests in Akili Interactivepacbiztimes.com
- Psychiatric drug startup launches with $500M, Amgen partnershipbizjournals.com
Amgen Files Reply Brief in Sandoz v. Amgenjdsupra.com- Amgen Declines to Seek Cert in Amgen v. Sandozjdsupra.com
- PAmgen CFO retiring in 2020pacbiztimes.com
Gradual Progress In Precision Non-Oncology, But Challenges PersistForbes- Intel invests in Raleigh startupbizjournals.com
Google Invests in Chinese Startupwsj.com- RGA invests in fintech startupbizjournals.com
- SImpact of Amgen reorganization in T.O. unclearsimivalleyacorn.com
- PAmgen laying off 150 workers in Massachusettspacbiztimes.com
- PAmgen revenues up 8 percent in 2015pacbiztimes.com
- PAmgen launches Humira biosimilar in Europepacbiztimes.com